Records containing: Stage IVA Prostate Cancer AJCC v8
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-24DS3201 With Ipilimumab in Patients With Metastatic Aggressive Variant Prostate (AVPC), Urothelial (UC), and Renal Cell (RCC) Carcinomas
-
CLINICAL_TRIALS study record update · 2026-04-15Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases
-
CLINICAL_TRIALS study record update · 2026-04-15A Phase 2 Course Determining Study for Men With Hormone-Naïve Metastatic Prostate Cancer (HNMPCa)
-
CLINICAL_TRIALS study record update · 2026-04-13Phase I/II Study of CDK4/6 Inhibition With Abemaciclib to Upregulate PSMA Expression Prior to 177Lu-PSMA-617 Treatment in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC) Previously Treated With Novel Hormonal Agents and Chemotherapy
-
CLINICAL_TRIALS study record update · 2026-04-06MC230504 Safe Omission of Pelvic Lymph Node Dissection (SOuND ) During Radical Prostatectomy: Diagnostic Accuracy of rhPSMA-7.3(18F) PET/CT, mpMRI and Patient Clinical Factors to Predict Lymph Node Metastasis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-03The Phase III 'High Five Trial' Five Fraction Radiation For High-Risk Prostate Cancer
-
CLINICAL_TRIALS study record update · 2026-04-03Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT*)
-
CLINICAL_TRIALS study record update · 2026-03-30Radiologically Guided Biopsies of Metastatic Castration Resistant Prostate Cancer to Identify Mechanisms of Resistance in Patients Undergoing 177Lu-PSMA Radioligand Therapy
-
CLINICAL_TRIALS study record update · 2026-03-16A Phase 2, Study of Apalutamide and Abiraterone Acetate in Castration-Resistant Metastatic Prostate Cancer Patients Evaluating a Predetermined Biomarker Signature
-
CLINICAL_TRIALS study record update · 2026-02-24Randomized Controlled Trial of Leuprolide Plus Abiraterone Acetate (AA) Versus Relugolix Plus AA for Advanced Prostate Cancer: The REVELUTION-2 Trial
-
CLINICAL_TRIALS study record update · 2026-02-19Phase II Trial of Primary Radiotherapy With Androgen Ablation With or Without Adjuvant Niraparib for Selected High-Risk Locoregional Prostate Cancer
-
CLINICAL_TRIALS study record update · 2026-02-06A Study of Erdafitinib in Castration-Resistant Prostate Cancer Patients Evaluating Markers of Bone Remodeling and FGF Signaling in Plasma and Bone Marrow
-
CLINICAL_TRIALS study record update · 2026-02-05CASPAR - A Phase III Trial of Enzalutamide and Rucaparib as a Novel Therapy in First-Line Metastatic Castration-Resistant Prostate Cancer
-
CLINICAL_TRIALS study record update · 2026-02-04NCORP Tissue Procurement Protocol: An NCI Cancer Moonshot Study
-
CLINICAL_TRIALS study record update · 2026-01-28Phase II Study of Talazoparib With Androgen Deprivation Therapy and Abiraterone in Castration Sensitive Prostate Cancer
-
CLINICAL_TRIALS study record update · 2026-01-15High-dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer Patients
-
CLINICAL_TRIALS study record update · 2026-01-14Randomized Phase III Trial Incorporating Apalutamide and Advanced Imaging Into Salvage Treatment for Patients With Node-Positive Prostate Cancer After Radical Prostatectomy (INNOVATE*) *INtensifying Treatment for NOde Positive Prostate Cancer by VArying the Hormonal ThErapy
-
CLINICAL_TRIALS study record update · 2025-12-22A Phase 2 Trial of ADT Interruption in Patients Responding Exceptionally to AR-Pathway Inhibitor in Metastatic Hormone-Sensitive Prostate Cancer (MHSPC): A-DREAM
-
CLINICAL_TRIALS study record update · 2025-12-05Remote Perioperative Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
-
CLINICAL_TRIALS study record update · 2025-11-12Post Operative External Beam Radiotherapy for Prostate Cancer: Randomized Trial Comparing Standard vs. Hypofractionated Radiation Therapy (PORT-HYFX)
-
CLINICAL_TRIALS study record update · 2025-11-12A Phase 1b Clinical Trial: Improving Outcomes With Androgen Pathway Inhibitors by Targeting DNA Methyltransferase Activity
-
CLINICAL_TRIALS study record update · 2025-10-14Phase I/II Study to Evaluate the Safety and Tolerability of Avelumab in Combination With Other Anti-Cancer Therapies in Patients With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2025-09-11Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer
-
CLINICAL_TRIALS study record update · 2025-08-29A Randomized, Phase II Clinical Trial of Time-Restricted Eating Versus Nutritional Counseling in Cancer Patients Receiving Radiation or Chemoradiation to Evaluate Its Impact on Toxicity and Efficacy
-
CLINICAL_TRIALS study record update · 2025-07-22A Phase 2 Study of BET Bromodomain Inhibitor ZEN-3694 in Combination With Enzalutamide Plus Pembrolizumab in Metastatic Castration Resistant Prostate Cancer